Downloads provided by UsageCounts
This is the expression value predicted using PrediXcan version 7 to find a gene feature that can distinguish between patients with and without effect on infliximab. Among the various tissue models provided by PrediXcan v7, three models were selected and used: whole blood, Colon transverse, and terminal ileum of small intestine, and the predicted gene counts of each model were 6,294, 5,612 and 3,107. For each of the three models, predicted gene expression values and phenotype information per sample were submitted.
{"references": ["Gamazon ER\u2020, Wheeler HE\u2020, Shah KP\u2020, Mozaffari SV, Aquino-Michaels K, Carroll RJ, Eyler AE, Denny JC, Nicolae DL, Cox NJ, Im HK. (2015) A gene-based association method for mapping traits using reference transcriptome data. Nat Genet. doi:10.1038/ng.3367."]}
PrediXcan, Crohn's disease, IBD, non-durable response, NDR, infliximab, Inflammatory bowel disease, CD
PrediXcan, Crohn's disease, IBD, non-durable response, NDR, infliximab, Inflammatory bowel disease, CD
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 6 | |
| downloads | 8 |

Views provided by UsageCounts
Downloads provided by UsageCounts